OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract A118: Identification of resistance mechanisms to FGFR4 targeted therapy in hepatocellular carcinoma

HTML

Year: 2019
Type: conference-abstract
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.targ-19-a118
Authors: Megan A Hatlen, Oleg Schmidt-Kittler, Cori-Ann Sherwin, Emily Rozsahegyi, Nooreen Rubin, Michael Sheets, Joseph L Kim, Chandra Miduturu, Neil Bifulco, Natasja Brooijmans, Hongliang Shi, Timothy Guzi, Andy Boral, Christoph Lengauer, Marion Dorsch, Richard D Kim, Yoon-Koo Kang, Beni B Wolf, Klaus P Hoeflich
Institutions: Blueprint Medicines (United States), Moffitt Cancer Center, Asan Medical Center, University of Ulsan
Language: English

Topic: Fibroblast Growth Factor Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: hepatocellular carcinoma, FGFR4, drug resistance, FGF19, gatekeeper mutation, tyrosine kinase inhibitors, oncogenic drivers, resistance mutations, pan-FGFR inhibitor, paracrine signaling, structure-based drug design, predictive biomarkers, liquid chromatography-tandem mass spectrometry
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2993740971
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security